1 / 12

An Economic and Policy Analysis of the Market for Methylphenidate and Amphetamine

An Economic and Policy Analysis of the Market for Methylphenidate and Amphetamine. Rick Mayes University of Richmond Farasat Bokhari University of California, Berkeley NRSA Conference, November 2002 National Institutes of Health. Background & Significance. What is ADHD ?

nerita
Download Presentation

An Economic and Policy Analysis of the Market for Methylphenidate and Amphetamine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. An Economic and Policy Analysis of the Market for Methylphenidate and Amphetamine Rick MayesUniversity of Richmond Farasat Bokhari University of California, Berkeley NRSA Conference, November 2002 National Institutes of Health

  2. Background & Significance • What is ADHD? • behavioral disorder marked by excessive inattentiveness and/or hyperactivity-impulsivity • So what? Why should anybody care? • the most commonly diagnosed behavioral disorder in children • ~ 3-5% of school-age children have the disorder; some estimates range as high as 7-12% (range: 1.5-6 million kids) • ~ 75-80% of children diagnosed with ADHD are treated with psychostimulant drugs • most powerful, addictive drugs that are legal (classified as Schedule II by Drug Enforcement Administration, DEA) • Society for Neuroscience (2001): Long term use may change the genetic composition of the brain • ~ $1 billion spent in 2000 on ADHD related drugs

  3. Diagnostic and Prescribing Trends • 400% increase in ADHD diagnoses in 1990s: • 1990 approximately 800,000 to 950,000 children diagnosed with ADHD • 2000 approximately 4 to 5 million children diagnosed with ADHD • Production and prescriptions of methylphenidate and amphetamine for treatment of ADHD have increased by about 800-900% since 1991.

  4. Per Capita Ritalin Use Over Time (1981-1996)

  5. Methylphenidate and Amphetamine Distribution, 2000 (DEA data)(average=4,150 grams/100,000 individuals) grams/per 10,000 Individuals 0 to 1600 Low (4.6%) 1600 to 3150 Below Average (25.5%) 3150 to 5150 Average (43.5%) 5150 to 6750 Above Average (19.6%) 6750 to 8350 High (4.9%) 8350 to 11000 Extremely High (1.8%)

  6. Research Question & Methodology • Do economic, social, and demographic factors, as well as regulation and education policies, influence the consumption of psychostimulant drugs? Specifically, what factors affect the demand and supply of these drugs, how do they determine consumption rates, and which ones are relatively more important? • Specify a market-level structural model of the consumption of psychostimulants (methylphenidate and amphetamine) to test hypotheses regarding the effect of social, economic, demographic (age, sex, race, ethnicity), state regulatory, school policy, health system, and other educational variables on the supply and demand for these drugs. • The model consists of a demand equation, a supply equation, and an equilibrium condition • The endogenous variables are the consumption rates and the price of the drug.

  7. Model Specification Structural Model • Where i is the market and t is the time period, Q is the quantity per capita and P is the price per unit. The coefficients (b’s) are to be estimated • X and Y are vectors of covariates that influence supply • X and Z are vectors of covariates that influence demand Objective: Test hypotheses regarding demand shifters

  8. Market Analysis: Exogenous Variables • Vector Z (exogenous variables in demand equation) • Economic factors (per capita income, unemployment rate) • Demographic Variables (e.g. population density, percent children, gender ratios, race-ethnic mix) • Educational Policies and School Characteristics (e.g. student attributes, instructional capacity and resources, instructional structure, teacher accountability and/or financial rewards) • Medical community (e.g., physicians by specialty, age and experience) • Vector Y (exogenous variables in supply equation) • Competition among pharmacies (pharmacies per capita),state laws regulating the interaction between HMOs, providers and pharmacies • Vector X (exogenous variables in both equations) • State Regulations re monitoring Schedule II drugs; presence of managed care, (HMO penetration and # of HMOs)

  9. Market Analysis: Estimation • System Over Identified • vectors Y and Z each appear in one equation and not the other • Vector Y is theinstrument for price in the demand equation. • Y consists of pharmacies per capita, and state laws indicating presence of AWP and FOC laws regarding HMOs and pharmacies • Single Eq. Estimators (IV/2SLS) And System Estimators (iterated 3SLS/FIML) is the matrix of correlations across equations (for unit i at time t) and is the most general form for • Fixed effects

  10. Characteristics of Children With and Without ADHD

  11. Characteristics of Children With and Without ADHD

  12. Counties With Low and High Ritalin Use

More Related